Felix Olale

Dr. Felix Olale is an entrepreneur and physician scientist, renowned for his work in building businesses and investing in healthcare in emerging markets. Prior to his current role as CEO of Signios Biosciences, he served as the Chairman of the MedGenome Board and was Partner and the Global Co-Leader for Health Investments at LeapFrog Investments. He also serves as a Board Trustee and Chairman of the Governance Committee for PATH, a leading global health innovator and is a member of EMPEA’s Africa Council. Dr. Olale has previously been the Chairman of the Excelsior Group and Senior Advisor to the International Finance Corporation (IFC). He was also the co-founder of Strathmore Business School’s Institute for Healthcare Management, and a founding member of Safaricom’s Health Advisory Board. Dr. Olale holds a Bachelor of Arts (Hons.) in Molecular Biology from the University of Pennsylvania and Medical Degree and Doctorate from New York University’s School of Medicine.